In the end, Gates and pharma won the legal case, and Gates helped push through enduring bullet-proof protection for pharmaceutical patents by his implacable support of the Trade-Related Aspects of Intellectual Property (TRIPS), an international agreement that outlawed the use of unsanctioned generics to combat AIDS and other diseases.
